[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@flobrand](/creator/twitter/flobrand) "1/5 BREAKING: Another strong quarter for J&Js psychedelic-like blockbuster SPRAVATO with annualized run-rate now closer to $2B. Q325 WW sales: $459M (US $405M) +61% y/y. Simple annualized (4Q3) $1.84B; FY25 likely around $1.7B. $ATAI $CMPS $MNMD $GHRS" [X Link](https://x.com/flobrand/status/1978057131791163697) [@flobrand](/creator/x/flobrand) 2025-10-14T11:15Z 3415 followers, 4315 engagements "1/ 🤯 Big news for biotech: Google / DeepMind just released a 27B-parameter foundation model (C2S-Scale 27B) for single-cell analysis and used it to discover a novel experimentally validated cancer immunotherapy hypothesis" [X Link](https://x.com/flobrand/status/1978754644244337129) [@flobrand](/creator/x/flobrand) 2025-10-16T09:27Z 3415 followers, XXX engagements "1/ Big congrats to my Co-Founder @SriniGRao @C_Angermayer Cosmo and the entire teams at @ataiLife & @BeckleyPsytech on receiving FDA Breakthrough Therapy Designation (BTD) for BPL-003 (5-MeO-DMT) in treatment-resistant depression 👏 🔗" [X Link](https://x.com/flobrand/status/1978939825970364671) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3412 followers, 1336 engagements "5/ This suggests markets may still underestimate the probability of success (PoS) of BTD assets. And psychedelics like BPL-003 may be further derisked given their growing late-stage clinical evidence across multiple programs. 🧠" [X Link](https://x.com/flobrand/status/1978939837182050801) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3411 followers, XXX engagements "6/ Exciting times ahead for short-acting psychedelics and the future of in-clinic mental-health treatments. 🌄 #Psychedelics #Biotech #FDA #MentalHealth #BTD #BPL003 #TRD" [X Link](https://x.com/flobrand/status/1978939839874544085) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3411 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@flobrand
"1/5 BREAKING: Another strong quarter for J&Js psychedelic-like blockbuster SPRAVATO with annualized run-rate now closer to $2B. Q325 WW sales: $459M (US $405M) +61% y/y. Simple annualized (4Q3) $1.84B; FY25 likely around $1.7B. $ATAI $CMPS $MNMD $GHRS"
X Link @flobrand 2025-10-14T11:15Z 3415 followers, 4315 engagements
"1/ 🤯 Big news for biotech: Google / DeepMind just released a 27B-parameter foundation model (C2S-Scale 27B) for single-cell analysis and used it to discover a novel experimentally validated cancer immunotherapy hypothesis"
X Link @flobrand 2025-10-16T09:27Z 3415 followers, XXX engagements
"1/ Big congrats to my Co-Founder @SriniGRao @C_Angermayer Cosmo and the entire teams at @ataiLife & @BeckleyPsytech on receiving FDA Breakthrough Therapy Designation (BTD) for BPL-003 (5-MeO-DMT) in treatment-resistant depression 👏 🔗"
X Link @flobrand 2025-10-16T21:43Z 3412 followers, 1336 engagements
"5/ This suggests markets may still underestimate the probability of success (PoS) of BTD assets. And psychedelics like BPL-003 may be further derisked given their growing late-stage clinical evidence across multiple programs. 🧠"
X Link @flobrand 2025-10-16T21:43Z 3411 followers, XXX engagements
"6/ Exciting times ahead for short-acting psychedelics and the future of in-clinic mental-health treatments. 🌄 #Psychedelics #Biotech #FDA #MentalHealth #BTD #BPL003 #TRD"
X Link @flobrand 2025-10-16T21:43Z 3411 followers, XXX engagements
/creator/twitter::86717586/posts